Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ark Genomic Revolution ETF (NY: ARKG )

25.38 +0.29 (+1.16%)
Streaming Delayed Price Updated: 2:39 PM EDT, Jun 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ark Genomic Revolution ETF

< Previous 1 2 3 4 5 6 7 8 Next >
3 Top Growth ETFs to Buy Right Now
These growth ETFs should deliver strong returns in the next bull market. 
Via The Motley Fool
Topics ETFs
Cathie Wood Continues To Cash Out Of Nvidia: Here's Another Large-Cap AI-Levered Stock Ark Sold Thursday
Cathie Wood's Ark Invest sold more Nvidia shares of Nvidia as the fund manager harps on the stock's stretched valuation. 
Via Benzinga
Cathie Wood Buys Roblox, Palantir Dips — Ark Invest Seizes Buying Opportunities Following Earnings Reports
Via Benzinga
Palantir Post Q2 Earnings Share Price Dip Doesn't Deter Cathie Wood — Ark Invest Buys $14M Worth Of Shares
Via Benzinga
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
Via Benzinga
Cathie Wood's Ark Invest Acquires $5.5M of Robinhood Shares Following Platform's First Profitable Quarter
Via Benzinga
Cathie Wood Continues Iridium Shopping Spree — Ark Invest Buys $3.6M Worth Of Satellite Company's Stock
Via Benzinga
Cathie Wood Buys $3.4M Worth Of Shares In This Payments Software Firm — Also Increases Exposure To Iridium Stock
Via Benzinga
Downgrade Aside, Cathie Wood Buys $1.2M Worth Of SoFi Shares
Via Benzinga
Cathie Wood Is Buying Up Shares of This Beaten-Down Biotech. Should You?
Moderna shares have declined over the past year amid concerns about post-pandemic vaccine sales. 
Via The Motley Fool
Cathie Wood's Ark Invest Continues To Sell Shares Of Warren Buffett-Backed BYD — Coinbase Holdings Trimmed As Well
Via Benzinga
2 No-Brainer Cathie Wood Stocks to Buy Right Now
Vertex Pharmaceuticals and Pfizer should be stellar long-term buys. 
Via The Motley Fool
Moderna On Cathie Wood's Radar Ahead Of Q2 Results: Ark Boosts Stake In COVID-19 Vaccine Maker By $12M This Week
Cathie Wood's Ark Invest bought over $12 million worth of Moderna shares as the biopharma expands its pipeline beyond COVID-19. 
Via Benzinga
Cathie Wood's Ark Invest Makes Major Moves In This Warren Buffett-Backed EV Company, Moderna
Via Benzinga
Why Shares of Quantum-Si Jumped This Week
Institutional buying, led by Cathie Wood's ARK Genomic Revolution ETF, spurred other investors to buy the stock. 
Via The Motley Fool
Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks
Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%. 
Via Talk Markets
Does Cathie Wood Have Her Hands on the Next Big Semiconductor Stock?
Wood's company recently invested millions into a semiconductor company that might not be on your radar. 
Via The Motley Fool
Why Quantum-Si Stock Was Highly Volatile Today
Despite falling in today's trading, Quantum-Si stock still gained 17.6% this week. 
Via The Motley Fool
Cathie Wood's Ark Invest Continues Tesla Selling Spree Despite Stock's Rise, AI Potential
Via Benzinga
S&P 500 Rallies Back To Highs As Apple, Nvidia Lead, But Watch For This; Tesla Deliveries Due
Many stocks flashed buy signals. But was the pullback over too quickly? 
Via Investor's Business Daily
ETF Returns: Mid-Cap Winners And Losers
We performed a screening of mid-cap ETFs - defined as having Assets Under Management (AUM) between $2 billion and $10 billion - to determine what funds had the largest positive and negative returns on... 
Via Benzinga
Cathie Wood's Ark Outshines S&P 500, Nasdaq In H1: Here Are The Major Trades It Made
Via Benzinga
This Big Cathie Wood Stock Is Outperforming Even Tesla
DraftKings is the strongest performer among Ark Invest's major holdings. 
Via Investor's Business Daily
Evogene - A Company With Valuable Assets Trading At Zero Enterprise Value
From a sum-of-parts perspective, Evogene is likely worth many multiples of its market valuation today, even without ascribing any value to Evogene’s technology. 
Via Talk Markets
Here's the Secret Behind Cathie Wood's Latest Moneymaking Strategy
Success could be in the DNA of the Ark Invest founder. 
Via The Motley Fool
Your Guide to All 6 Cathie Wood ETFs
Here's what investors need to know about all the Ark Invest ETFs. 
Via The Motley Fool
A Bull Market Is Coming: These 2 Cathie Wood Stocks Could Skyrocket
Wood sees the long-term potential in these two innovators. 
Via The Motley Fool
Cathie Wood Trimmed This Big Tech Stock Holding But Bulked Up On SaaS Provider PagerDuty And Ginkgo Bioworks
Via Benzinga
Cathie Wood Sells More Nvidia Shares After Rally: Here's How Many Shares Ark Funds Owns Of AI Giant
One of the most notable exchange-traded fund families may have sold shares of Nvidia Corporation (NASDAQ: NVDA) early. The Ark Funds ETFs have continued selling Nvidia shares since the company reported... 
Via Benzinga
Did Cathie Wood's Innovation ARKK ETF Whiff On AI? How It Compares To FAANG, Nvidia In 2023
One of the most recognizable investing names of the last decade is Ark Funds CEO Cathie Wood. With an eye on high-growth stocks and innovation, the Ark Funds outperformed the market for years during... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.